blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1940837

EP1940837 - IMIDAZOPYRIDINE COMPOUNDS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  13.09.2013
Database last updated on 11.09.2024
Most recent event   Tooltip17.07.2015Lapse of the patent in a contracting state
New state(s): HU		published on 19.08.2015  [2015/34]
Applicant(s)For all designated states
Takeda Pharmaceutical Company Limited
1-1, Doshomachi 4-chome Chuo-ku Osaka-shi
Osaka 541-0045 / JP
For all designated states
Takeda California, Inc.
10410 Science Center Drive
San Diego, CA 92121 / US
[2012/22]
Former [2012/16]For all designated states
Takeda Pharmaceutical Company Limited
1-1, Doshomachi 4-chome Chuo-ku Osaka-shi
Osaka 541-0045 / JP
For all designated states
Takeda Corporation, Inc.
2711 Centerville Road, Suite 400
Wilmington, NC 19808 / US
Former [2008/28]For all designated states
Takeda Pharmaceutical Company Limited
1-1, Doshomachi 4-chome Chuo-ku Osaka-shi
Osaka 541-0045 / JP
For all designated states
Takeda San Diego, Inc.
10410 Science Center Drive
San Diego CA 92121 / US
Inventor(s)01 / IWATA, Hidehisa
C/O TAKEDA PHARMACEUTICAL COMPANY LIMITED
17-85, Jusohonmachi 2-Chome
Yodogawa-ku, Osaka-shi
Osaka, 532-8686 / JP
02 / KOHARA, Yasuhisa
C/O TAKEDA PHARMACEUTICAL COMPANY LIMITED
17-85, Jusohonmachi 2-Chome
Yodogawa-ku, Osaka-shi
Osaka, 532-8686 / JP
03 / CAO, Sheldon X.
10521 Sand Crab Place
San Diego, CA 92130 / US
04 / GUNTUPALLI, Prasuna
6323 Oleander Way
San Diego, CA 92130 / US
05 / GWALTNEY, Stephen L.
12246 Dormouse Road
San Diego, CA 92129 / US
06 / HOSFIELD, David J.
425 S. Rios Avenue
Solana Beach, CA 92075 / US
07 / LIU, Yan
5382 Greenwillow Lane
San Diego, CA 92130 / US
08 / STAFFORD, Jeffrey A.
12752 Sandy Crest Court
San Diego, CA 92130 / US
09 / THROOP, Beverly
12761 Jordan Ridge Court
San Diego, CA 92120 / US
 [2012/45]
Former [2008/28]01 / IWATA, Hidehisa
C/O TAKEDA PHARMACEUTICAL COMPANY LIMITED 17-85, Jusohonmachi 2-Chome Yodogawa-ku, Osaka-shi
Osaka, 532-8686 / JP
02 / KOHARA, Yasuhisa
C/O TAKEDA PHARMACEUTICAL COMPANY LIMITED 17-85, Jusohonmachi 2-Chome Yodogawa-ku, Osaka-shi
Osaka, 532-8686 / JP
03 / CAO, Sheldon X.
10521 Sand Crab Place
San Diego, CA 92130 / US
04 / GUNTUPALLI, Prasuna
6323 Oleander Way
San Diego, CA 92130 / US
05 / GWALTNEY, Stephen L.
12246 Dormouse Road
San Diego, CA 92129 / US
06 / HOSFIELD, David J.
425 S. Rios Avenue
Solana Beach, CA 92075 / US
07 / LIU, Yan
5382 Greenwillow Lane
San Diego, CA 92130 / US
08 / STAFFORD, Jeffrey A.
12752 Sandy Crest Court
San Diego, CA 92130 / US
09 / THROOP, Beverly
12761 Jordan Ridge Court
San Diego, CA 92120 / US
Representative(s)Duncan, Garreth Andrew, et al
D Young & Co LLP
120 Holborn
London EC1N 2DY / GB
[N/P]
Former [2012/45]Duncan, Garreth Andrew, et al
D Young & Co LLP 120 Holborn London
EC1N 2DY / GB
Former [2008/28]Duncan, Garreth Andrew, et al
D Young & Co 120 Holborn London
EC1N 2DY / GB
Application number, filing date06802913.101.09.2006
[2008/28]
WO2006US34441
Priority number, dateJP2005025419401.09.2005         Original published format: JP 2005254194
[2008/50]
Former [2008/28]JP20050254194U01.09.2005
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2007028135
Date:08.03.2007
Language:EN
[2007/10]
Type: A2 Application without search report 
No.:EP1940837
Date:09.07.2008
Language:EN
The application published by WIPO in one of the EPO official languages on 08.03.2007 takes the place of the publication of the European patent application.
[2008/28]
Type: B1 Patent specification 
No.:EP1940837
Date:07.11.2012
Language:EN
[2012/45]
Search report(s)International search report - published on:EP01.11.2007
ClassificationIPC:C07D471/04, A61K31/437, A61P5/48
[2008/28]
CPC:
A61K31/437 (EP,US); A61K9/2018 (EP,US); A61K9/4858 (EP,US);
A61P1/00 (EP); A61P1/02 (EP); A61P1/04 (EP);
A61P1/12 (EP); A61P1/16 (EP); A61P1/18 (EP);
A61P11/00 (EP); A61P13/02 (EP); A61P13/12 (EP);
A61P15/00 (EP); A61P17/00 (EP); A61P19/00 (EP);
A61P19/02 (EP); A61P19/06 (EP); A61P19/10 (EP);
A61P21/04 (EP); A61P25/00 (EP); A61P25/02 (EP);
A61P25/26 (EP); A61P27/02 (EP); A61P27/12 (EP);
A61P27/16 (EP); A61P29/00 (EP); A61P3/04 (EP);
A61P3/06 (EP); A61P3/10 (EP); A61P31/00 (EP);
A61P31/18 (EP); A61P35/00 (EP); A61P35/02 (EP);
A61P37/04 (EP); A61P37/08 (EP); A61P43/00 (EP);
A61P5/00 (EP); A61P5/28 (EP); A61P5/30 (EP);
A61P5/48 (EP); A61P7/00 (EP); A61P9/00 (EP);
A61P9/04 (EP); A61P9/08 (EP); A61P9/10 (EP);
A61P9/12 (EP); C07D471/02 (EP,US); C07D471/04 (EP,US);
C12N9/1205 (EP,US); C12Y207/01001 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2008/28]
Extension statesAL12.03.2008
BA12.03.2008
HR12.03.2008
MK12.03.2008
RS12.03.2008
TitleGerman:IMIDAZOPYRIDINVERBINDUNGEN[2008/28]
English:IMIDAZOPYRIDINE COMPOUNDS[2008/28]
French:COMPOSES A BASE D'IMIDAZOPYRIDINE[2008/28]
Entry into regional phase12.03.2008National basic fee paid 
12.03.2008Designation fee(s) paid 
12.03.2008Examination fee paid 
Examination procedure12.03.2008Examination requested  [2008/28]
24.11.2008Despatch of a communication from the examining division (Time limit: M04)
01.04.2009Reply to a communication from the examining division
22.09.2010Despatch of a communication from the examining division (Time limit: M04)
18.01.2011Reply to a communication from the examining division
27.07.2011Despatch of a communication from the examining division (Time limit: M02)
29.09.2011Reply to a communication from the examining division
10.05.2012Communication of intention to grant the patent
07.09.2012Fee for grant paid
07.09.2012Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  24.11.2008
Opposition(s)08.08.2013No opposition filed within time limit [2013/42]
Fees paidRenewal fee
25.09.2008Renewal fee patent year 03
25.09.2009Renewal fee patent year 04
27.09.2010Renewal fee patent year 05
26.09.2011Renewal fee patent year 06
25.09.2012Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU01.09.2006
AT07.11.2012
BE07.11.2012
CY07.11.2012
CZ07.11.2012
DK07.11.2012
EE07.11.2012
FI07.11.2012
IT07.11.2012
LT07.11.2012
LV07.11.2012
MC07.11.2012
NL07.11.2012
PL07.11.2012
RO07.11.2012
SE07.11.2012
SI07.11.2012
SK07.11.2012
TR07.11.2012
BG07.02.2013
GR08.02.2013
ES18.02.2013
IS07.03.2013
PT07.03.2013
[2015/34]
Former [2015/32]AT07.11.2012
BE07.11.2012
CY07.11.2012
CZ07.11.2012
DK07.11.2012
EE07.11.2012
FI07.11.2012
IT07.11.2012
LT07.11.2012
LV07.11.2012
MC07.11.2012
NL07.11.2012
PL07.11.2012
RO07.11.2012
SE07.11.2012
SI07.11.2012
SK07.11.2012
TR07.11.2012
BG07.02.2013
GR08.02.2013
ES18.02.2013
IS07.03.2013
PT07.03.2013
Former [2014/20]AT07.11.2012
BE07.11.2012
CY07.11.2012
CZ07.11.2012
DK07.11.2012
EE07.11.2012
FI07.11.2012
IT07.11.2012
LT07.11.2012
LV07.11.2012
MC07.11.2012
NL07.11.2012
PL07.11.2012
RO07.11.2012
SE07.11.2012
SI07.11.2012
SK07.11.2012
BG07.02.2013
GR08.02.2013
ES18.02.2013
IS07.03.2013
PT07.03.2013
Former [2013/37]AT07.11.2012
BE07.11.2012
CY07.11.2012
CZ07.11.2012
DK07.11.2012
EE07.11.2012
FI07.11.2012
IT07.11.2012
LT07.11.2012
LV07.11.2012
NL07.11.2012
PL07.11.2012
RO07.11.2012
SE07.11.2012
SI07.11.2012
SK07.11.2012
BG07.02.2013
GR08.02.2013
ES18.02.2013
IS07.03.2013
PT07.03.2013
Former [2013/35]AT07.11.2012
BE07.11.2012
CY07.11.2012
CZ07.11.2012
DK07.11.2012
EE07.11.2012
FI07.11.2012
LT07.11.2012
LV07.11.2012
NL07.11.2012
PL07.11.2012
SE07.11.2012
SI07.11.2012
SK07.11.2012
BG07.02.2013
GR08.02.2013
ES18.02.2013
IS07.03.2013
PT07.03.2013
Former [2013/34]AT07.11.2012
BE07.11.2012
CY07.11.2012
DK07.11.2012
FI07.11.2012
LT07.11.2012
LV07.11.2012
NL07.11.2012
PL07.11.2012
SE07.11.2012
SI07.11.2012
BG07.02.2013
GR08.02.2013
ES18.02.2013
IS07.03.2013
PT07.03.2013
Former [2013/31]AT07.11.2012
BE07.11.2012
CY07.11.2012
FI07.11.2012
LT07.11.2012
LV07.11.2012
NL07.11.2012
PL07.11.2012
SE07.11.2012
SI07.11.2012
GR08.02.2013
ES18.02.2013
IS07.03.2013
PT07.03.2013
Former [2013/28]BE07.11.2012
CY07.11.2012
FI07.11.2012
LT07.11.2012
LV07.11.2012
NL07.11.2012
PL07.11.2012
SE07.11.2012
SI07.11.2012
GR08.02.2013
ES18.02.2013
IS07.03.2013
PT07.03.2013
Former [2013/27]BE07.11.2012
CY07.11.2012
FI07.11.2012
LT07.11.2012
LV07.11.2012
NL07.11.2012
PL07.11.2012
SE07.11.2012
SI07.11.2012
GR08.02.2013
ES18.02.2013
IS07.03.2013
Former [2013/26]CY07.11.2012
FI07.11.2012
LT07.11.2012
LV07.11.2012
NL07.11.2012
PL07.11.2012
SE07.11.2012
SI07.11.2012
GR08.02.2013
ES18.02.2013
IS07.03.2013
Former [2013/24]CY07.11.2012
FI07.11.2012
LT07.11.2012
LV07.11.2012
NL07.11.2012
PL07.11.2012
SE07.11.2012
GR08.02.2013
ES18.02.2013
IS07.03.2013
Former [2013/23]CY07.11.2012
FI07.11.2012
LT07.11.2012
LV07.11.2012
NL07.11.2012
PL07.11.2012
SE07.11.2012
ES18.02.2013
IS07.03.2013
Former [2013/22]FI07.11.2012
LT07.11.2012
NL07.11.2012
SE07.11.2012
ES18.02.2013
IS07.03.2013
Former [2013/21]LT07.11.2012
SE07.11.2012
Former [2013/20]LT07.11.2012
Cited inInternational search[X]DE2305339  (THOMAE GMBH DR K) [X] 3-8,12,14,15 * Compounds of general formula I as well as Ia;; claims 1,2,9 *;
 [X]DE1445824  (GEIGY AG J R) [X] 3,8,12,14,15 * claims 1,11,12,46 *;
 [X]WO03026587  (SQUIBB BRISTOL MYERS CO [US]) [X] 3-8 * page 31, compound 64;;; claim 1 *;
 [X]JP2001192653  (FUJI PHOTO FILM CO LTD) [X] 12 * page 25 - page 26 *;
 [E]EP1702919  (BANYU PHARMA CO LTD [JP]) [E] 1-17 * the whole document *
 [X]  - YUTILOV Y M ET AL, "Preparation of 2-aryl-substituted derivatives of imidazo[4,5-b]pyridine and imidazo[4,5-c]pyridine", CHEMISTRY OF HETEROCYCLIC COMPOUNDS (A TRANSLATION OF KHIMIYA GETEROTSIKLICHESKIKH SOEDINENII), PLENUM PRESS CO., NEW YORK, NY, US, (1987), no. 5, ISSN 0009-3122, pages 639 - 645, XP002231885 [X] 12 * page 529; compound IF *
by applicantWO2005063738
 WO0138325
 WO0125228
 WO03042204
 WO9844921
 WO9845285
 WO9922735
 WO9710224
 WO0182925
 WO0187834
    - THE JOURNAL OF BIOLOGICAL CHEMISTRY, (1995), vol. 270, pages 30253 - 30256
    - THE JOURNAL OF BIOLOGICAL CHEMISTRY, (1997), vol. 272, pages 22564 - 22569
    - THE JOURNAL OF BIOLOGICAL CHEMISTRY, (1997), vol. 272, pages 22570 - 22575
    - JAPAN CLINICAL, (2002), vol. 60, pages 523 - 534
    - CELL, (1995), vol. 83, pages 69 - 78
    - NATURE, (1992), vol. 356, pages 721 - 722
    - NEW ENGLAND JOURNAL MEDICINE, (1998), vol. 338, pages 226 - 230
    - "Development of Pharmaceutical Products", Molecule Design, HIROKAWA SHOTEN, (1990), vol. 7, pages 163 - 198
    - COMPREHENSIVE HETEROCYCLIC CHEMISTRY II, (1996), vol. 7, pages 313 - 316
    - J. AM. CHEM. SOC., (2003), vol. 125, pages 5707 - 5716
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.